{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:23:41Z","timestamp":1777958621194,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,8,26]],"date-time":"2015-08-26T00:00:00Z","timestamp":1440547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00228-015-1925-9","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T01:55:03Z","timestamp":1440467703000},"page":"1341-1347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C\u2009>\u2009T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children"],"prefix":"10.1007","volume":"71","author":[{"given":"Limin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,26]]},"reference":[{"key":"1925_CR1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1528-1167.2008.01866.x","volume":"50","author":"JJ Moeller","year":"2009","unstructured":"Moeller JJ, Rabey SR, Sadler RM (2009) Lamotrigine-valproic acid combination therapy for medically refractory epilepsy. Epilepsia 50:475\u2013479","journal-title":"Epilepsia"},{"key":"1925_CR2","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.55.4.588","volume":"55","author":"AM Kanner","year":"2000","unstructured":"Kanner AM, Frey M (2000) Adding valproate to lamotrigine: a study of their pharmacokinetic interaction. Neurology 55:588\u2013591","journal-title":"Neurology"},{"key":"1925_CR3","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archneur.62.9.1432","volume":"62","author":"D Weintraub","year":"2005","unstructured":"Weintraub D, Buchsbaum R, Resor SR et al (2005) Effect of antiepileptic drug comedication on lamotrigine clearance. Arch Neurol 62:1432\u20131436","journal-title":"Arch Neurol"},{"key":"1925_CR4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0920-1211(00)00160-1","volume":"42","author":"BE Gidal","year":"2000","unstructured":"Gidal BE, Anderson GD, Rutecki PR et al (2000) Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy. Epilepsy Res 42:23\u201331","journal-title":"Epilepsy Res"},{"key":"1925_CR5","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/dmd.106.009340","volume":"34","author":"A Rowland","year":"2006","unstructured":"Rowland A, Elliot DJ, Williams JA et al (2006) In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction. Drug Metab Dispos 34:1055\u20131062","journal-title":"Drug Metab Dispos"},{"key":"1925_CR6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.clpt.6100324","volume":"83","author":"JY Chung","year":"2008","unstructured":"Chung JY, Cho JY, Yu KS et al (2008) Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects. Clin Pharmacol Ther 83:595\u2013600","journal-title":"Clin Pharmacol Ther"},{"key":"1925_CR7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/17425255.2.6.1009","volume":"2","author":"V Biton","year":"2006","unstructured":"Biton V (2006) Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy. Expert Opin Drug Metab Toxicol 2:1009\u20131018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1925_CR8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/mol.59.3.405","volume":"59","author":"RH Tukey","year":"2001","unstructured":"Tukey RH, Strassburg CP (2001) Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol Pharmacol 59:405\u2013414","journal-title":"Mol Pharmacol"},{"key":"1925_CR9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.fpc.0000173483.13689.56","volume":"15","author":"PI Mackenzie","year":"2005","unstructured":"Mackenzie PI, Bock KW, Burchell B et al (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677\u2013685","journal-title":"Pharmacogenet Genomics"},{"key":"1925_CR10","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0022-3565(25)11424-9","volume":"260","author":"J Magdalou","year":"1992","unstructured":"Magdalou J, Herber R, Bidault R et al (1992) In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes. J Pharmacol Exp Ther 260:1166\u20131173","journal-title":"J Pharmacol Exp Ther"},{"key":"1925_CR11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/00498250902745082","volume":"39","author":"UA Argikar","year":"2009","unstructured":"Argikar UA, Remmel RP (2009) Variation in glucuronidation of lamotrigine in human liver microsomes. Xenobiotica 39:355\u2013363","journal-title":"Xenobiotica"},{"key":"1925_CR12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1006990925122","volume":"19","author":"TA Ketter","year":"1999","unstructured":"Ketter TA, Frye MA, Cora-Locatelli G et al (1999) Metabolism and excretion of mood stabilizers and new anticonvulsants. Cell Mol Neurobiol 19:511\u2013532","journal-title":"Cell Mol Neurobiol"},{"key":"1925_CR13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0022-3565(25)10294-2","volume":"264","author":"C Jin","year":"1993","unstructured":"Jin C, Miners JO, Lillywhite KJ et al (1993) Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid containing drugs. J Pharmcol Exp Ther 264:475\u2013479","journal-title":"J Pharmcol Exp Ther"},{"key":"1925_CR14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/dmd.108.022426","volume":"37","author":"UA Argikar","year":"2009","unstructured":"Argikar UA, Remmel RP (2009) Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10. Drug Metab Dispos 37:229\u2013236","journal-title":"Drug Metab Dispos"},{"key":"1925_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2011.01.016","volume":"95","author":"MI Gulcebi","year":"2011","unstructured":"Gulcebi MI, Ozkaynakc\u0131 A, Goren MZ et al (2011) The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy. Epilepsy Res 95:1\u20138","journal-title":"Epilepsy Res"},{"key":"1925_CR16","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2217\/pgs.11.105","volume":"12","author":"J Zhou","year":"2011","unstructured":"Zhou J, Argikar UA, Remmel RP (2011) Functional analysis of UGT1A4 (P24T) and UGT1A4 (L48V) variant enzymes. Pharmacogenomics 12:1671\u20131679","journal-title":"Pharmacogenomics"},{"key":"1925_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/FTD.0b013e3181ceecc6","volume":"32","author":"M Blanca S\u00e1nchez","year":"2010","unstructured":"Blanca S\u00e1nchez M, Herranz JL, Leno C et al (2010) UGT2B7_-161C>T polymorphism is associated with lamotrigine concentration-to-dose ratio in a multivariate study. Ther Drug Monit 32:177\u2013184","journal-title":"Ther Drug Monit"},{"key":"1925_CR18","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1248\/bpb.30.2146","volume":"30","author":"Y Takekuma","year":"2007","unstructured":"Takekuma Y, Takenaka T, Yamazaki K et al (2007) Stereoselective metabolism of racemic carvedilol by UGT1A1 and UGT2B7, and effects of mutation of these enzymes on glucuronidation activity. Biol Pharm Bull 30:2146\u20132153","journal-title":"Biol Pharm Bull"},{"key":"1925_CR19","first-page":"101","volume":"9","author":"Y Takekuma","year":"2006","unstructured":"Takekuma Y, Takenaka T, Kiyokawa M (2006) Contribution of polymorphisms in UDP-glucuronosyltransferase and CYP2D6 to the individual variation in disposition of carvedilol. J Pharm Pharm Sci 9:101\u2013112","journal-title":"J Pharm Pharm Sci"},{"key":"1925_CR20","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.bcp.2011.08.004","volume":"82","author":"W Haina","year":"2011","unstructured":"Haina W, Lingmin Y, Su Z (2011) Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen. Biochem Pharmacol 82:1757\u20131763","journal-title":"Biochem Pharmacol"},{"key":"1925_CR21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0009-9236(03)00053-5","volume":"73","author":"MB Sawyer","year":"2003","unstructured":"Sawyer MB, Innocenti F, Das S et al (2003) A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine. Clin Pharmacol Ther 73:566\u2013574","journal-title":"Clin Pharmacol Ther"},{"key":"1925_CR22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2003.09.008","volume":"57","author":"BE Gidal","year":"2003","unstructured":"Gidal BE, Sheth R, Parnell J et al (2003) Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy. Epilepsy Res 57:85\u201393","journal-title":"Epilepsy Res"},{"key":"1925_CR23","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1007\/s11033-012-1615-y","volume":"39","author":"N Hakooz","year":"2012","unstructured":"Hakooz N, Alzubiedi S, Yousef AM et al (2012) UDP-glucuronosyltransferase 1A4 (UGT1A4) polymorphisms in a Jordanian population. Mol Biol Rep 39:7763\u20137768","journal-title":"Mol Biol Rep"},{"key":"1925_CR24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clinbiochem.2006.01.002","volume":"39","author":"K Saito","year":"2006","unstructured":"Saito K, Moriya H, Sawaguchi T et al (2006) Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects. Clin Biochem 39:303\u2013308","journal-title":"Clin Biochem"},{"key":"1925_CR25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/toxsci\/kfi068","volume":"85","author":"GF Lin","year":"2005","unstructured":"Lin GF, Guo WC, Chen JG et al (2005) An association of UDP-glucuronosyltransferase 2B7 C802T (His268Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China. Toxicol Sci 85:502\u2013506","journal-title":"Toxicol Sci"},{"key":"1925_CR26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.tpj.6500171","volume":"3","author":"C Guillemette","year":"2003","unstructured":"Guillemette C (2003) Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 3:136\u2013158","journal-title":"Pharmacogenomics J"},{"key":"1925_CR27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/0008-5472.CAN-05-2857","volume":"66","author":"J Thibaudeau","year":"2006","unstructured":"Thibaudeau J, Le\u00b4pine J, Tojcic J et al (2006) Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone. Cancer Res 66:125\u2013133","journal-title":"Cancer Res"},{"key":"1925_CR28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/FPC.0b013e3283037fe4","volume":"18","author":"F Innocenti","year":"2008","unstructured":"Innocenti F, Liua W, Fackenthal D et al (2008) Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene. Pharmacogenet Genomics 18:683\u2013697","journal-title":"Pharmacogenet Genomics"},{"key":"1925_CR29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.tpj.6500327","volume":"5","author":"JR Ross","year":"2005","unstructured":"Ross JR, Rutter D, Welsh K et al (2005) Clinical response to morphine in cancer patients and genetic variation in candidate genes. Pharmacogenomics J 5:324\u2013336","journal-title":"Pharmacogenomics J"},{"key":"1925_CR30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2125.2007.02923.x","volume":"64","author":"VC Peterkin","year":"2007","unstructured":"Peterkin VC, Bauman JN, Goosen TC et al (2007) Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes. Br J Clin Pharmacol 64:458\u2013468","journal-title":"Br J Clin Pharmacol"},{"key":"1925_CR31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/JCP.0b013e31824997a8","volume":"32","author":"M Mao","year":"2012","unstructured":"Mao M, Skogh E, Scordo MG et al (2012) Interindividual variation in olanzapine concentration influenced by UGT1A4 L48V polymorphism in serum and upstream FMO polymorphisms in cerebrospinal fluid. J Clin Psychopharmacol 32:287\u2013289","journal-title":"J Clin Psychopharmacol"},{"key":"1925_CR32","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1124\/dmd.104.002576","volume":"33","author":"A Mori","year":"2005","unstructured":"Mori A, Maruo Y, Iwai M et al (2005) UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation. Drug Metab Dispos 33:672\u2013675","journal-title":"Drug Metab Dispos"},{"key":"1925_CR33","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1124\/dmd.107.015214","volume":"35","author":"SJ Miyagi","year":"2007","unstructured":"Miyagi SJ, Collier AC (2007) Pediatric development of glucuronidation: the ontogeny of hepatic UGT1A4. Drug Metab Dispos 35:1587\u20131592","journal-title":"Drug Metab Dispos"},{"key":"1925_CR34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.50.2.259","volume":"50","author":"CP Strassburg","year":"2002","unstructured":"Strassburg CP, Strassburg A, Kneip S et al (2002) Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut 50:259\u2013265","journal-title":"Gut"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1925-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-015-1925-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-015-1925-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T04:18:07Z","timestamp":1748578687000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-015-1925-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,26]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["1925"],"URL":"https:\/\/doi.org\/10.1007\/s00228-015-1925-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,26]]}}}